Akiyoshi Animal Clinic, Yamato City, Kanagawa, Japan.
Vet Med Sci. 2021 Nov;7(6):2103-2107. doi: 10.1002/vms3.612. Epub 2021 Aug 17.
A 7-year-old spayed female Scottish Fold cat presented with a 4-week history of anorexia, weight loss and vomiting. Abdominal ultrasonography revealed a jejunal mass and a slightly enlarged jejunal lymph node. A fine-needle aspiration of the mass revealed many round cells with multiple small intracytoplasmic magenta granules. The mass was diagnosed as a large granular lymphocyte (LGL) lymphoma based on cytology. The LGL lymphoma was completely resected via open surgery. The histologic and cytologic evaluations showed no neoplastic findings in the jejunal lymph node, liver, spleen, kidney or bone marrow. The LGL lymphoma was localized to the jejunum. Postoperatively, the cat received chemotherapy with nimustine, L-asparaginase and prednisolone. The cat is currently receiving nimustine every 6 weeks, without adverse events, and treatment has been administrated a total of 18 times up until day 552. The cat is in a good condition, and the LGL lymphoma has not recurred. Nimustine should be considered one of the effective chemotherapeutic agents in the treatment of feline LGL lymphoma cases in the future.
一只 7 岁已绝育的雌性苏格兰折耳猫,出现 4 周的厌食、体重减轻和呕吐症状。腹部超声检查显示空肠有肿块和稍大的空肠淋巴结。肿块的细针抽吸显示有许多圆形细胞,细胞内有多个小的紫红色颗粒。基于细胞学,该肿块被诊断为大颗粒淋巴细胞(LGL)淋巴瘤。通过开放性手术完全切除 LGL 淋巴瘤。组织学和细胞学评估显示空肠淋巴结、肝脏、脾脏、肾脏或骨髓均无肿瘤发现。LGL 淋巴瘤局限于空肠。术后,猫接受了尼莫司汀、L-天冬酰胺酶和泼尼松龙化疗。目前,这只猫每 6 周接受一次尼莫司汀治疗,没有出现不良反应,治疗总共进行了 18 次,直到第 552 天。这只猫状况良好,LGL 淋巴瘤未复发。尼莫司汀在未来应被视为治疗猫 LGL 淋巴瘤的有效化疗药物之一。